Tuesday, May 21 2013 9:56 PM EDT2013-05-22 01:56:07 GMT
People in Pat O'Hagan's small hometown of Sheffield say there is a bit a closure. That this week's developments end some of the two-and-a half year old mystery. Friends and neighbors say all this beginsMore >>
People in Pat O'Hagan's small hometown of Sheffield say there is a bit a closure.More >>
Tuesday, May 21 2013 7:29 PM EDT2013-05-21 23:29:47 GMT
Chittenden Solid Waste District general manager Tom Moreau says the chemical aminopyralid is the herbicide found in Green Mountain Compost that ruined up to five hundred gardens last year including his. "We'reMore >>
The herbicide likely came from hay that came to the compost through manure.More >>
Tuesday, May 21 2013 7:23 PM EDT2013-05-21 23:23:32 GMT
For the first time in more than a year, we're hearing from the couple accused of brutally killing a popular St. Johnsbury teacher, Melissa Jenkins. Both Allen and Patricia Prue spoke in court today -More >>
For the first time in more than a year, we're hearing from the couple accused of brutally killing a popular St. Johnsbury teacher, Melissa Jenkins. Both Allen and Patricia Prue spoke in court today - requesting new attorneys. More >>
Tuesday, May 21 2013 6:25 PM EDT2013-05-21 22:25:01 GMT
Voters across the state of New York headed to the polls on Tuesday to vote on their school districts budgets and elect school board members. For voters in Peru, NY the reaction to the proposed budget isMore >>
Voters across the state of New York headed to the polls on Tuesday to vote on their school districts budgets and elect school board members. More >>
Tuesday, May 21 2013 6:10 PM EDT2013-05-21 22:10:06 GMT
South Burlington fire fighters say they had to close off some streets Tuesday to repair a gas leak. It happened around 2 on Hayes Avenue, as construction crews were working on a street project. FirefightersMore >>
South Burlington fire fighters say they had to close off some streets Tuesday to repair a gas leak.More >>
Tuesday, May 21 2013 5:44 PM EDT2013-05-21 21:44:30 GMT
For more than two and half years we haven't heard much from police about the death of Pat O'Hagan. That changed Tuesday when we received these federal documents that connects Michael Norrie, 22, KeithMore >>
Even with confessions of three people regarding the death of Pat O'Hagan, state prosecutors say there isn't enough evidence to charge them. Instead, federal prosecutors are hoping to use that information to lock at least one of them behind bars for a longer time.More >>
Tuesday, May 21 2013 3:32 PM EDT2013-05-21 19:32:47 GMT
Here's a timeline of events regarding Pat O'Hagan's death. On September 10, 2010, police say 78-year-old Pat O'Hagan was attacked and killed inside her Sheffield, Vt. home.The next day a friend reportedMore >>
Timeline of events regarding Pat O'Hagan's death.More >>
Tuesday, May 21 2013 2:32 PM EDT2013-05-21 18:32:54 GMT
Vermont Restaurant Week donates $6,600 to Vermont Food Bank. A press release says the money will provide 19,800 meals for families throughout Vermont "The Vermont Food Bank is thrilled to again be theMore >>
Vermont Restaurant Week donates $6,600 to Vermont Foodbank.More >>
Tuesday, May 21 2013 1:43 PM EDT2013-05-21 17:43:40 GMT
A judge denied Allen Prue's request for a new lawyer Tuesday. Earlier Tuesday, a judge also denied Patricia Prue, Allen's wife, a new lawyer. Patricia and Allen Prue are accused of strangling and beatingMore >>
A judge denied Allen Prue's request for a new lawyer Tuesday.More >>
Tuesday, May 21 2013 1:22 PM EDT2013-05-21 17:22:01 GMT
If you're looking to help the victims of the deadly tornado in Oklahoma here are some resources: Red Cross You can also text REDCROSS to: 90999. Each text will donate $10 and will be charged to your phoneMore >>
If you're looking to help the victims of the deadly tornado in Oklahoma here are some resources. More >>
Information contained on this page is provided by companies via press release distributed through PR Newswire, an independent third-party content provider. PR Newswire, WorldNow and this Station make no warranties or representations in connection therewith.
SOURCE Boston Scientific Corporation
WATCHMAN® Device Continues to Demonstrate Positive Clinical Outcomes for Patients with Atrial Fibrillation
NATICK, Mass., March 9, 2013 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) announces the preliminary analysis of the PREVAIL clinical trial data is now available on TCTMD at http://www.tctmd.com/show.aspx?id=118115. PREVAIL evaluates the safety and efficacy of the WATCHMAN® Left Atrial Appendage (LAA) Closure device in patients with nonvalvular atrial fibrillation versus long-term warfarin therapy.
The company inadvertently broke the American College of Cardiology (ACC) embargo policy surrounding the PREVAIL clinical trial data, which were to be presented at the 62nd Annual Sessions of the American College of Cardiology in the Late-Breaking Clinical Trial presentation on Saturday, March 9, 2013. As a result of the inadvertent error, ACC canceled the presentation.
"Boston Scientific considers scientific exchange in a peer-reviewed setting to be of the utmost importance and we deeply regret that the data were not shared at ACC," said Kenneth Stein, M.D., chief medical officer, Cardiac Rhythm Management, Boston Scientific.
In the United States, WATCHMAN is an investigational device, limited by applicable law to investigational use and not available for sale.
About Boston Scientific Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for more than 30 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information, visit www.bostonscientific.com and connect on Twitter and Facebook.
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements may be identified by words like "anticipate," "expect," "project," "believe," "plan," "estimate," "intend" and similar words. These forward-looking statements are based on our beliefs, assumptions and estimates using information available to us at the time and are not intended to be guarantees of future events or performance. These forward-looking statements include, among other things, statements regarding regulatory approvals, clinical trials, product performance and competitive offerings. If our underlying assumptions turn out to be incorrect, or if certain risks or uncertainties materialize, actual results could vary materially from the expectations and projections expressed or implied by our forward-looking statements. These factors, in some cases, have affected and in the future (together with other factors) could affect our ability to implement our business strategy and may cause actual results to differ materially from those contemplated by the statements expressed in this press release. As a result, readers are cautioned not to place undue reliance on any of our forward-looking statements.
Factors that may cause such differences include, among other things: future economic, competitive, reimbursement and regulatory conditions; new product introductions; demographic trends; intellectual property; litigation; financial market conditions; and future business decisions made by us and our competitors. All of these factors are difficult or impossible to predict accurately and many of them are beyond our control. For a further list and description of these and other important risks and uncertainties that may affect our future operations, see Part I, Item 1A – Risk Factors in our most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission, which we may update in Part II, Item 1A – Risk Factors in Quarterly Reports on Form 10-Q we have filed or will file hereafter. We disclaim any intention or obligation to publicly update or revise any forward-looking statements to reflect any change in our expectations or in events, conditions or circumstances on which those expectations may be based, or that may affect the likelihood that actual results will differ from those contained in the forward-looking statements. This cautionary statement is applicable to all forward-looking statements contained in this document.
CONTACT: Steven Campanini 508-652-5740 (office) 214-546-5034 (March 9-11 during ACC) Global Media Relations Boston Scientific Corporation email@example.com